Neal C. Bradsher, Director, 10% Owner at Lineage Cell Therapeutics, Inc. (LCTX), bought 1,190,212 shares at $1.42 ($1.7M) on 2022-03-24, disclosed to the SEC on 2022-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.37 | 260,106 | $356K | 21.3% |
| 2 | $1.37 | 260,106 | $356K | 21.3% |
| 3 | $1.42 | 200,000 | $284K | 17.0% |
| 4 | $1.44 | 470,000 | $677K | 40.4% |
| Total | $1.41 avg | 1,190,212 | $1.7M | 100% |
| Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-11-21 | $82.1M | — | Filing → |
| STAA | BUY | 2025-04-10 | $5.4M | — | Filing → |